
Xilio Therapeutics (XLO) Market Capitalization Overview
Market Cap: $41.14M as of Mar 10, 2026
$41.14M
$4.57M (12.48%)past month
As of Mar 10, 2026, Xilio Therapeutics (XLO) has a market capitalization of $41.14M. Over the past 30 days, its market cap has increased by 28.77%, while in the last 12 months, it has increased by 22.39%.
Market capitalization represents the total value of Xilio Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Xilio Therapeutics (XLO) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Xilio Therapeutics (XLO) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Xilio Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Xilio Therapeutics (XLO) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Xilio Therapeutics (XLO) helps investors assess the company's size and compare it with competitors for better investment decisions.
Xilio Therapeutics (XLO) Market Cap & Key Trends
See Xilio Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Xilio Therapeutics (XLO)
Order type
Buy in
Order amount
Est. shares
0 shares
Xilio Therapeutics (XLO) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $38.83M | -11.87% |
| Nov 3, 2025 | $44.06M | +2.08% |
| Oct 1, 2025 | $43.16M | +18.15% |
| Sep 2, 2025 | $36.53M | +8.51% |
| Aug 1, 2025 | $33.66M | -6.20% |
| Jul 1, 2025 | $35.89M | -1.01% |
| Jun 2, 2025 | $36.26M | -7.26% |
| May 1, 2025 | $39.10M | +10.87% |
| Apr 1, 2025 | $35.26M | -14.85% |
| Mar 3, 2025 | $41.41M | +36.13% |
| Feb 3, 2025 | $30.42M | -35.33% |
| Jan 2, 2025 | $47.04M | +2.88% |
Xilio Therapeutics (XLO) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $41.14M | +22.39% |
| 2025 | $33.62M | -19.94% |
| 2024 | $41.98M | +177.26% |
| 2023 | $15.15M | -79.46% |
| 2022 | $73.73M | -82.72% |
| 2021 | $426.66M | — |
FAQs About Xilio Therapeutics (XLO) Market Cap
As of Mar 10, 2026, the market capitalization of Xilio Therapeutics (XLO) is $41.14M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Xilio Therapeutics’s market capitalization has increased by 12.48%, changing from $36.58M to $41.14M as of Mar 10, 2026.
In the last 3 months, Xilio Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Xilio Therapeutics’s market capitalization decreased from $41.98M in January to $33.62M in December, reflecting a -19.94% change.
In the past five years, Xilio Therapeutics (XLO) has had a compound annual growth rate (CAGR) of -39.84% in market capitalization. This means its market cap has shrunk at an average rate of -39.84% per year.